Ultrasensitive, multiplex Raman frequency shift immunoassay of liver cancer biomarkers in physiological media

ACS Nano

Volumn 10, Issue 1, 2016, Pages 871-879

  Tang, Bochong ^a   Wang, Jiaojiao ^a,b   Hutchison, James A ^c,d   Ma, Lei ^a   Zhang, Ning ^e   Guo, Hua ^e   Hu, Zhongbo ^b   Li, Min ^a   Zhao, Yuliang ^a  

^a INSTITUTE OF HIGH ENERGY PHYSICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Frequency shift immunoassay; Liver cancer biomarkers; Microcontact printing ( CP); Multiplex detection; SERS

Indexed keywords

BODY FLUIDS; DIAGNOSIS; DISEASES; ELECTRON DEVICE MANUFACTURE; FREQUENCY SHIFT KEYING; IMMUNOLOGY; MULTIPLEXING; PRINTING; RAMAN SCATTERING; RAMAN SPECTROSCOPY; SILVER; SURFACE SCATTERING;

FREQUENCY SHIFT; LIVER CANCERS; MICRO CONTACT PRINTING; MULTIPLEX DETECTIONS; SERS;

BIOMARKERS;

ALPHA FETOPROTEIN; ANTIBODY; DIMETICONE; GLYPICAN; METAL NANOPARTICLE; NYLON; POLY(DIMETHYLSILOXANE)-POLYAMIDE COPOLYMER; SILVER; TUMOR MARKER;

ANIMAL; BLOOD; BOVINE; CARCINOMA, HEPATOCELLULAR; CHEMISTRY; DEVICES; EARLY DIAGNOSIS; HUMAN; IMMUNOASSAY; LIVER NEOPLASMS; PRINTING; PROCEDURES; RAMAN SPECTROMETRY; SENSITIVITY AND SPECIFICITY; ULTRASTRUCTURE;

ALPHA-FETOPROTEINS; ANIMALS; ANTIBODIES; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; CATTLE; DIMETHYLPOLYSILOXANES; EARLY DIAGNOSIS; GLYPICANS; HUMANS; IMMUNOASSAY; LIVER NEOPLASMS; METAL NANOPARTICLES; NYLONS; PRINTING; SENSITIVITY AND SPECIFICITY; SILVER; SPECTRUM ANALYSIS, RAMAN;

EID: 84990946795     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/acsnano.5b06007     Document Type: Article

References (38)

1. International Agency for Research on Cancer. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012; IARC: Lyon, France 2013; http://globocan.iarc.fr/ (accessed May, 2015).
2. Arzumanyan, A.; Reis, H. M.; Feitelson, M. A. Pathogenic Mechanisms in HBV- and HCV-Associated Hepatocellular Carcinoma. Nat. Rev. Cancer 2013, 13, 123-135.
3. Australian Institute of Health and Welfare. Cancer Incidence Projections: Australia, 2011 to 2020; Cancer Series no. 66, Cat. No. CAN 62; AIHW; Canberra, Australia; 2012; http://www.aihw.gov.au (accessed May, 2015).
4. Yu, C.; Qian, L.; Uttamchandani, M.; Li, L.; Yao, S. Q. Single- Vehicular Delivery of Antagomir and Small Molecules to Inhibit miR-122 Function in Hepatocellular Carcinoma Cells by using "Smart" Mesoporous Silica Nanoparticles. Angew. Chem., Int. Ed. 2015, 54, 10574-10578.
5. World Gastroenterology Organisation Global Guidelines: Hepatocellular Carcinoma (HCC): A Global Perspective; World Gastroenterology Organisation: Milwaukee, WI, 2009; www.worldgastroenterology.org (accessed May, 2015).
6. Xu, L.; Hazard, F. K.; Zmoos, A. F.; Jahchan, N.; Chaib, H.; Garfin, P. M.; Rangaswami, A.; Snyder, M. P.; Sage, J. Genomic Analysis of Fibrolamellar Hepatocellular Carcinoma. Hum. Mol. Genet. 2015, 24, 50-63.
7. Wu, L. J.; Pan, Y. D.; Pei, X. Y.; Chen, H.; Nguyen, S.; Kashyap, A.; Liu, J.; Wu, J. Capturing Circulation Tumor Cells from Hepatocellular Carcinoma. Cancer Lett. 2012, 326, 17-22.
8. Wu, L.; Qu, X. Cancer Biomarker Detection: Recent Achievements and Challenges. Chem. Soc. Rev. 2015, 44, 2963-2997.
9. Lok, A. S.; Sterling, R K.; Everhart, J. E.; Wright, E. C.; Hoefs, J. C.; Di Bisceglie, A. M.; Morgan, T. R.; Kim, H. Y.; Lee, W. M.; Bonkovsky, H. L.; Dienstag, J. L. Des-/-Carboxy Prothrombin and Alpha-Fetoprotein as Biomarkers For the Early Detection of Hepatocellular Carcinoma. Gastroenterology 2010, 138, 493-502.
10. Dinish, U. S.; Balasundaram, G.; Chang, Y. T.; OLivo, M. Sensitive Multiplex Detection of Serological Liver Cancer Biomarkers Using SERS-Active Photonic Crystal Fiber Probe. J. Biophotonics 2014, 7, 956-965.
11. Yu, J. P.; Xu, X. G.; Ma, R.J.; Qin, S. N.; Wang, C. R.; Wang, X. B.; Li, M.; Li, M. S.; Ma, Q.; Xu, W. W. Development of a Clinical Chemiluminescent Immunoassay for Serum GPC3 and Simultaneous Measurements Alone With AFP and CK19 in Diagnosis of Hepatocellular Carcinoma. J. Clin. Lab. Anal. 2015, 29, 85-93.
12. Wang, Y. C.; Yang, H. Y.; Xu, H. F.; Lu, X.; Sang, X. T.; Zhong S. X.; Huang, J. F.; Mao, Y. L. Golgi Protein 73, not Glypican-3, May Be a Yumor Marker Complementary to Alpha-Fetoprotein for Hepatocel-lular Carcinoma Diagnosis. J. Gastroenterol. Hepatol. 2014, 29, 597-602.
13. Marrero, J. A.; Feng, Z.; Wang, Y.; Nguyen, M. H.; Befeler, A. S.; Roberts, L. R.; Reddy, K. R.; Harnois, D.; Llovet, J. M.; Normolle, D.; Dalhgren, J.; Chia, D.; Lok, A. S.; Wagner, P. D.; Srivastava, S.; Schwartz, M. α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Boundα-Fetoprotein in Early Hepatocellular Carcinoma. Gastroenterology 2009, 137, 110-118.
14. Biselli, M.; Conti, F.; Gramenzi, A.; Frigerio, M.; Cucchetti, A.; Fatti, G.; D'Angelo, M.; Dall'Agata, M.; Giannini, E. G.; Farinati, F. A New Approach to The Use ofAlpha-Fetoprotein as Surveillance Test for Hepatocellular Carcinoma in Patients With Cirrhosis. Br. J. Cancer 2015, 112, 69-76.
15. Capurro, M.; Wanless, I. R.; Sherman, M.; Deboer, G.; Shi, W.; Miyoshi, E.; Filmus, J. Glypican-3: A Novel Serum and Histochemical Marker for Hepatocellular Carcinoma. Gastroenterology 2003, 125, 89-97.
16. Le Ru, E.; Etchegoin, P. Principles of Surface-Enhanced Raman Spectroscopy and related plasmonic effects, 1st ed.; Elsevier: Amsterdam, 2008.
17. Porter, M. D.; Lipert, R. J.; Siperko, L. M.; Wang, G.; Narayanan, R. SERS As a Bioassay Platform: Fundamentals, Design, and Applications. Chem. Soc. Rev. 2008, 37, 1001-1011.
18. Wang, G.; Lipert, R. J.; Jain, M.; Kaur, S.; Chakraboty, S.; Torres, M. P.; Batra, S. K.; Brand, R E.; Porter, M. D. Detection of The Potential Pancreatic Cancer Marker MUC4 in Serum Using Surface-Enhanced Raman Scattering. Anal. Chem. 2011 , 83, 2554-2561.
19. Granger, J. H.; Granger, M. C.; Firpo, M. A.; Mulvihill, S. J.; Porter, M. D. Toward Development of A Surface-Enhanced Raman Scattering (SERS)-Based Cancer Diagnostic Immunoassay Panel. Analyst 2013, 138, 410-416.
20. Harper, M. M.; McKeating, K. S.; Faulds, K. Recent Developments and Future Directions in SERS for Bioanalysis. Phys. Chem. Chem. Phys. 2013, 15, 5312-5328.
21. Li, M.; Cushing S. K.; Zhang, J.; Suri, S.; Evans, R.; Petros, W. P.; Gibson, L. F.; Ma, D.; Liu, Y.; Wu, N. Three-Dimensional Hierarchical Plasmonic Nano-Architecture Enhanced Surface-Enhanced Raman Scattering Immunosensor for Cancer Biomarker Detection in Blood Plasma. ACS Nano 2013, 7, 4967-4976.
22. Wang, Y.; Vaidyanathan, R.; Shiddiky, M. J. A.; Trau, M. Enabling Rapid and Specific Surface-Enhanced Raman Scattering Immunoassay Using Nanoscaled Surface Shear Forces. ACS Nano 2015, 9, 6354-6362.
23. Devi, R. V.; Doble, M.; Verma, R. S. Nanomaterials for Early Detection of Cancer Biomarker with Special Emphasis on Gold Nanoparticles in Immunoassays/Sensors. Biosens. Bioelectron. 2015, 68, 688-698.
24. Cao, Y. C.; Jin, R. C.; Nam, J.-M.; Thaxton, C. S.; Mirkin, C. A. Raman Dye-Labeled Nanoparticle Probes for Proteins. J. Am. Chem. Soc. 2003, 125, 14676-14677.
25. Guerrini, L.; Krpetic, Z.; van Lierop, D.; Alvarez-Puebla, R A.; Graham, D. Direct Surface-Enhanced Raman Scattering Analysis of DNA Duplexes. Angew. Chem., Int. Ed. 2015, 54, 1144-1148.
26. Ye, J.; Chen, Y.; Liu, Z. A Boronate Affinity Sandwich Assay: An Appealing Alternative to Immunoassays for the Determination of Glycoproteins. Angew. Chem., Int. Ed. 2014, 53, 10386-10389.
27. Cui, Y.; Ren, B.; Yao, J. L.; Gu, R. A.; Tian, Z. Q. Multianalyte Immunoassay Based on Surface-Enhanced Raman Spectroscopy. J. Raman Spectrosc. 2007, 38, 896-902.
28. Wang, G.; Park, H. Y.; Lipert, R. J.; Porter, M. D. Mixed Monolayers on Gold Nanoparticle Labels for Multiplexed Surface-Enhanced Raman Scattering Based Immunoassays. Anal. Chem. 2009, 81, 9643-9650.
29. Wang, Y.; Rauf, S.; Grewal, Y. S.; Spadafora, L. J.; Shiddiky, M. J. A. ; Cangelosi, G. A.; Schlucker, S.; Trau, M. Duplex Microfluidic SERS Detection of Pathogen Antigens with Nanoyeast Single-Chain Variable Fragments. Anal. Chem. 2014, 86, 9930-9938.
30. Kho, K. W.; Dinish, U. S.; Kumar, A.; Olivo, M. Frequency Shifts in SERS for Biosensing. ACS Nano 2012, 6, 4892-4902.
31. Guerrini, L.; Pazos, E.; Penas, C.; Vazquez, M. E.; Mascarems, J. L.; Alvarez-Puebla, R. A. Highly Sensitive SERS Quantification of the Oncogenic Protein c-Jun in Cellular Extracts. J. Am. Chem. Soc. 2013, 135, 10314-10317.
32. Wang, Y.; Ji, W.; Sui, H.; Kitahama, Y.; Ruan, W.; Ozaki, Y.; Zhao, B. Exploring the Effect of Intermolecular H-Bonding: A Study on Charge-Transfer Contribution to Surface-Enhanced Raman Scattering of p-Mercaptobenzoic Acid. J. Phys. Chem. C 2014, 118, 10191-10197.
33. Wang, Y.; Yu, Z.; Ji, W.; Tanaka, Y.; Sui, H. M.; Zhao, B.; Ozaki, Y. Enantioselective Discrimination of Alcohols by Hydrogen Bonding: A SERS Study. Angew. Chem, Int. Ed. 2014, 53, 13866-13870.
34. Perumal, J.; Kong, K. V.; Dinish, U. S.; Bakker, R. M.; Olivo, M. Design and Fabrication of Random Silver Films as Substrate for SERS Based Nano-Stress Sensing of Proteins. RSC Adv. 2014, 4, 12995-13000.
35. Grubisha, D. S.; Lipert, R. J.; Park, H. Y.; Driskell, J.; Porter, M. D. Femtomolar Detection of Prostate-Specific Antigen: An Immunoassay Based on Surface-Enhanced Raman Scattering and Immunogold Labels. Anal. Chem. 2003, 75, 5936-5943.
36. Xia, Y.; Whitesides, G. M. Soft Lithography. Angew. Chem., Int. Ed. 1998, 37, 550-575.
37. Whitesides, G. M.; Ostuni, E.; Takayama, S.; Jiang, X. Y.; Ingber, D. E. Soft Lithography in Biology and Biochemistry. Annu. Rev. Biomed. Eng. 2001, 3, 335-373.
38. Li, H.; Zhang, J.; Zhou, X.; Lu, G.; Yin, Z.; Li, G.; Wu, T.; Boey, F.; Venkatraman, S. S.; Zhang, H. Aminosilane Micropatterns on Hydroxyl-Terminated Substrates: Fabrication and Applications. Langmuir 2010, 26, 5603-5609.